Recent Press Releases

Management Insights and Media Coverage

Protective Effect of Astaxanthin on Liver Fibrosis through Modulation of TGF-β1 Expression and Autophagy. Shen et al.

By | Science

By Timothy J. King, Ph.D., Vice President, Research The role of oxidative stress and inflammation in liver injury and liver dysfunction as well as the potential for antioxidants to ameliorate liver disease has been established in both animal models and human trials [Sanchez-Valle et al. 2012; Pacana and Sanyal 2012]. Studies utilizing rodent models of liver disease have also demonstrated the efficacy of astaxanthin (ASTX) in ameliorating liver injury [Kang et al. 2001; Curek et…

Read More

Astaxanthin for the Treatment of Osteoarthritis, a Large Unmet Medical Need

By | Science

By Timothy J. King, Ph.D., Vice President, Research Osteoarthritis (OA) is the most common form of arthritis, a chronic disease of aging. Effective and safe long-term treatment for most OA patients is not available, creating a large unmet medical need. The potential market for OA is very large, where it is estimated that more than 150 million middle class people globally suffer from OA. Symptomatic knee OA alone affects roughly 12% of persons 60 years…

Read More

Company Contact

Cardax, Inc.
2800 Woodlawn Drive, #129
Honolulu, Hawaii 96822
Phone: (808) 457-1400
press@cardaxpharma.com